Cargando…
Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis
BACKGROUND: Ki-67 is an established marker of cell proliferation, and the Ki-67 index correlates with the clinical course of several cancer types, including bladder cancer (BC). However, the clinicopathological and prognostic significance of Ki-67 in bladder cancer remains unclear. Therefore, we per...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943634/ https://www.ncbi.nlm.nih.gov/pubmed/27410033 http://dx.doi.org/10.1371/journal.pone.0158891 |
_version_ | 1782442627240558592 |
---|---|
author | Tian, Yuejun Ma, Zhiming Chen, Zhaohui Li, Mingguo Wu, Zhiping Hong, Mei Wang, Hanzhang Svatek, Robert Rodriguez, Ronald Wang, Zhiping |
author_facet | Tian, Yuejun Ma, Zhiming Chen, Zhaohui Li, Mingguo Wu, Zhiping Hong, Mei Wang, Hanzhang Svatek, Robert Rodriguez, Ronald Wang, Zhiping |
author_sort | Tian, Yuejun |
collection | PubMed |
description | BACKGROUND: Ki-67 is an established marker of cell proliferation, and the Ki-67 index correlates with the clinical course of several cancer types, including bladder cancer (BC). However, the clinicopathological and prognostic significance of Ki-67 in bladder cancer remains unclear. Therefore, we performed a systematic review and meta-analysis to clarify this relationship. METHODS: A comprehensive literature search for relevant studies published up to February 1, 2016, was performed using PubMed, Cochrane Library, Embase and ISI Web of Knowledge. The effects of Ki-67 expression on survival outcome in patients with BC and BC subtypes were evaluated. Furthermore, the relationship between Ki-67 expression and the clinicopathological features of BC were assessed. RESULTS: Thirty-one studies with 5147 bladder cancer patients were selected for evaluation. Ki-67 expression was significantly associated with shorter recurrence-free (HR 1.69, 95% CI: 1.33–2.14), progression-free (HR 1.89, 95% CI: 1.43–2.51), overall (HR 2.03, 95% CI: 1.31–3.16), and cancer-specific (HR 1.69, 95% CI: 1.47–1.95) survival. Moreover, whereas high expression was more common in high tumor stage, recurrence status, tumor size, there was no correlation between high Ki-67 expression and age, gender, smoking habits, and tumor number. Importantly, analysis of the different subgroups of BC suggested that significant correlations between high Ki-67 expression and survival outcome (recurrence-free/progression-free/overall/cancer-specific survival) are present only in European-American patients. CONCLUSION: The present results indicate that over-expression of Ki-67 is distinctly correlated with poor patient survival. Ki-67 may serve as a valuable biomarker for prognosis in BC patients, particularly in non-Asian BC patients. The results suggest no significant association between Ki-67 expression and BC prognosis in Asian patients. Further efforts are needed to fully clarify this relationship. |
format | Online Article Text |
id | pubmed-4943634 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-49436342016-08-01 Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis Tian, Yuejun Ma, Zhiming Chen, Zhaohui Li, Mingguo Wu, Zhiping Hong, Mei Wang, Hanzhang Svatek, Robert Rodriguez, Ronald Wang, Zhiping PLoS One Research Article BACKGROUND: Ki-67 is an established marker of cell proliferation, and the Ki-67 index correlates with the clinical course of several cancer types, including bladder cancer (BC). However, the clinicopathological and prognostic significance of Ki-67 in bladder cancer remains unclear. Therefore, we performed a systematic review and meta-analysis to clarify this relationship. METHODS: A comprehensive literature search for relevant studies published up to February 1, 2016, was performed using PubMed, Cochrane Library, Embase and ISI Web of Knowledge. The effects of Ki-67 expression on survival outcome in patients with BC and BC subtypes were evaluated. Furthermore, the relationship between Ki-67 expression and the clinicopathological features of BC were assessed. RESULTS: Thirty-one studies with 5147 bladder cancer patients were selected for evaluation. Ki-67 expression was significantly associated with shorter recurrence-free (HR 1.69, 95% CI: 1.33–2.14), progression-free (HR 1.89, 95% CI: 1.43–2.51), overall (HR 2.03, 95% CI: 1.31–3.16), and cancer-specific (HR 1.69, 95% CI: 1.47–1.95) survival. Moreover, whereas high expression was more common in high tumor stage, recurrence status, tumor size, there was no correlation between high Ki-67 expression and age, gender, smoking habits, and tumor number. Importantly, analysis of the different subgroups of BC suggested that significant correlations between high Ki-67 expression and survival outcome (recurrence-free/progression-free/overall/cancer-specific survival) are present only in European-American patients. CONCLUSION: The present results indicate that over-expression of Ki-67 is distinctly correlated with poor patient survival. Ki-67 may serve as a valuable biomarker for prognosis in BC patients, particularly in non-Asian BC patients. The results suggest no significant association between Ki-67 expression and BC prognosis in Asian patients. Further efforts are needed to fully clarify this relationship. Public Library of Science 2016-07-13 /pmc/articles/PMC4943634/ /pubmed/27410033 http://dx.doi.org/10.1371/journal.pone.0158891 Text en © 2016 Tian et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Tian, Yuejun Ma, Zhiming Chen, Zhaohui Li, Mingguo Wu, Zhiping Hong, Mei Wang, Hanzhang Svatek, Robert Rodriguez, Ronald Wang, Zhiping Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis |
title | Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis |
title_full | Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis |
title_fullStr | Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis |
title_full_unstemmed | Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis |
title_short | Clinicopathological and Prognostic Value of Ki-67 Expression in Bladder Cancer: A Systematic Review and Meta-Analysis |
title_sort | clinicopathological and prognostic value of ki-67 expression in bladder cancer: a systematic review and meta-analysis |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943634/ https://www.ncbi.nlm.nih.gov/pubmed/27410033 http://dx.doi.org/10.1371/journal.pone.0158891 |
work_keys_str_mv | AT tianyuejun clinicopathologicalandprognosticvalueofki67expressioninbladdercancerasystematicreviewandmetaanalysis AT mazhiming clinicopathologicalandprognosticvalueofki67expressioninbladdercancerasystematicreviewandmetaanalysis AT chenzhaohui clinicopathologicalandprognosticvalueofki67expressioninbladdercancerasystematicreviewandmetaanalysis AT limingguo clinicopathologicalandprognosticvalueofki67expressioninbladdercancerasystematicreviewandmetaanalysis AT wuzhiping clinicopathologicalandprognosticvalueofki67expressioninbladdercancerasystematicreviewandmetaanalysis AT hongmei clinicopathologicalandprognosticvalueofki67expressioninbladdercancerasystematicreviewandmetaanalysis AT wanghanzhang clinicopathologicalandprognosticvalueofki67expressioninbladdercancerasystematicreviewandmetaanalysis AT svatekrobert clinicopathologicalandprognosticvalueofki67expressioninbladdercancerasystematicreviewandmetaanalysis AT rodriguezronald clinicopathologicalandprognosticvalueofki67expressioninbladdercancerasystematicreviewandmetaanalysis AT wangzhiping clinicopathologicalandprognosticvalueofki67expressioninbladdercancerasystematicreviewandmetaanalysis |